EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 21 / No 3 (Mars 2005) Med Sci (Paris), 21 3 (2005) 284-289 References
Free Access
Issue
Med Sci (Paris)
Volume 21, Number 3, Mars 2005
Page(s) 284 - 289
Section M/S revues
DOI https://doi.org/10.1051/medsci/2005213284
Published online 15 March 2005
  1. Wong CG, Gibson KM, Snead OC 3rd. From the street to the brain : neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends Pharmacol Sci 2004; 25 : 29–34. [Google Scholar]
  2. Laborit H, Jouany JM, Gerard J, Fabiani F. Generalities concerning the experimental study and clinical use of gamma hydroxybutyrate of Na. Agressologie 1960; 1 : 397–406. [Google Scholar]
  3. Borgen LA, Cook HN, Hornfeldt CS, Fuller DE. Sodium oxybate (GHB) for treatment of cataplexy. Pharmacotherapy 2002; 22 : 798–9. [Google Scholar]
  4. Hedou G, Chasserot-Golaz S, Kemmel V, et al. Immunohistochemical studies of the localization of neurons containing the enzyme that synthesizes dopamine, GABA, or gamma-hydroxybutyrate in the rat substantia nigra and striatum. J Comp Neurol 2000; 426 : 549–60. [Google Scholar]
  5. Maitre M. The gamma-hydroxybutyrate signalling system in brain : organization and functional implications. Prog Neurobiol 1997; 51 : 337–61. [Google Scholar]
  6. Muller C, Viry S, Miehe M, et al. Evidence for a gamma-hydroxybutyrate (GHB) uptake by rat brain synaptic vesicles. J Neurochem 2002; 80 : 899–904. [Google Scholar]
  7. Vayer P, Maitre M. Regional differences in depolarization-induced release of gamma-hydroxybutyrate from rat brain slices. Neurosci Lett 1988; 87 : 99–103. [Google Scholar]
  8. Benavides J, Rumigny JF, Bourguignon JJ, et al. A high-affinity, Na+-dependent uptake system for gamma-hydroxybutyrate in membrane vesicles prepared from rat brain. J Neurochem 1982; 38 : 1570–5. [Google Scholar]
  9. McCormick SJ, Tunnicliff G. Inhibitors of synaptosomal gamma-hydroxybutyrate transport. Pharmacology 1998; 57 : 124–31. [Google Scholar]
  10. Benavides J, Rumigny JF, Bourguignon JJ, et al. High affinity binding sites for gamma-hydroxybutyric acid in rat brain. Life Sci 1982; 30 : 953–61. [Google Scholar]
  11. Hechler V, Gobaille S, Maitre M. Selective distribution pattern of gamma-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography. Brain Res 1992; 572 : 345–8. [Google Scholar]
  12. Snead OC, 3rd. The ontogeny of 3Hgamma-hydroxybutyrate and 3HGABAB binding sites : relation to the development of experimental absence seizures. Brain Res 1994; 659 : 147–56. [Google Scholar]
  13. Ratomponirina C, Hode Y, Hechler V, Maitre M. Gamma-hydroxybutyrate receptor binding in rat brain is inhibited by guanyl nucleotides and pertussis toxin. Neurosci Lett 1995; 189 : 51–3. [Google Scholar]
  14. Andriamampandry C, Taleb O, Viry S, et al. Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB). FASEB J 2003; 17 : 1691–3. [Google Scholar]
  15. Ratomponirina C, Gobaille S, Hode Y, et al. Sulpiride, but not haloperidol, upregulates gamma-hydroxybutyrate receptors in vivo and in cultured cells. Eur J Pharmacol 1998; 346 : 331–7. [Google Scholar]
  16. Kemmel V, Taleb O, Andriamampandry C, et al. Gamma-hydroxybutyrate receptor function determined by stimulation of rubidium and calcium movements from NCB-20 neurons. Neuroscience 2003; 116 : 1021–31. [Google Scholar]
  17. Snead OC 3rd. Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor. J Neurochem 2000; 75 : 1986–96. [Google Scholar]
  18. Cash CD, Gobaille S, Kemmel V, et al. Gamma-hydroxybutyrate receptor function studied by the modulation of nitric oxide synthase activity in rat frontal cortex punches. Biochem Pharmacol 1999; 58 : 1815–9. [Google Scholar]
  19. Vayer P, Gobaille S, Mandel P, Maitre M. 3’-5’ cyclic-guanosine monophosphate increase in rat brain hippocampus after gamma-hydroxybutyrate administration. Prevention by valproate and naloxone. Life Sci 1987; 41 : 605–10. [Google Scholar]
  20. Kemmel V, Taleb O, Perard A, et al. Neurochemical and electrophysiological evidence for the existence of a functional gamma-hydroxybutyrate system in NCB- 20 neurons. Neuroscience 1998; 86 : 989–1000. [Google Scholar]
  21. Maitre M, Hechler V, Vayer P, et al. A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties. J Pharmacol Exp Ther 1990; 255 : 657–63. [Google Scholar]
  22. Howard SG, Feigenbaum JJ. Effect of gamma-hydroxybutyrate on central dopamine release in vivo. A microdialysis study in awake and anesthetized animals. Biochem Pharmacol 1997; 53 : 103–10. [Google Scholar]
  23. Brancucci A, Berretta N, Mercuri NB, Francesconi W. Gamma-hydroxybutyrate and ethanol depress spontaneous excitatory postsynaptic currents in dopaminergic neurons of the substantia nigra. Brain Res 2004; 997 : 62–6. [Google Scholar]
  24. Gobaille S, Hechler V, Andriamampandry C, et al. gamma-hydroxybutyrate modulates synthesis and extracellular concentration of gamma-aminobutyric acid in discrete rat brain regions in vivo. J Pharmacol Exp Ther 1999; 290 : 303–9. [Google Scholar]
  25. Hechler V, Gobaille S, Bourguignon JJ, Maitre M. Extracellular events induced by gamma-hydroxybutyrate in striatum : a microdialysis study. J Neurochem 1991; 56 : 938–44. [Google Scholar]
  26. Lingenhoehl K, Brom R, Heid J, et al. Gamma-hydroxybutyrate is a weak agonist at recombinant GABAB receptors. Neuropharmacology 1999; 38 : 1667–73. [Google Scholar]
  27. Kaupmann K, Cryan JF, Wellendorph P, et al. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABAB(1)-deficient mice. Eur J Neurosci 2003; 18 : 2722–30. [Google Scholar]
  28. Berton F, Brancucci A, Beghe F, et al. Gamma-hydroxybutyrate inhibits excitatory postsynaptic potentials in rat hippocampal slices. Eur J Pharmacol 1999; 380 : 109–16. [Google Scholar]
  29. Godbout R, Jelenic P, Labrie C, et al. Effect of gamma-hydroxybutyrate and its antagonist NCS-382 on spontaneous cell firing in the prefrontal cortex of the rat. Brain Res 1995; 673 : 157–60. [Google Scholar]
  30. Vacher CM, Bettler B. GABAB receptors as potential therapeutic targets. Curr Drug Target CNS Neurol Disord 2003; 2 : 248–59. [Google Scholar]
  31. Vayer P, Mandel P, Maitre M. Conversion of gamma-hydroxybutyrate to gamma-aminobutyrate in vitro. J Neurochem 1985; 45 : 810–4. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.